Wayne Linsley - Dec 29, 2021 Form 4/A - Amendment Insider Report for Silo Pharma, Inc. (SILO)

Role
Director
Signature
/s/ Wayne Linsley
Stock symbol
SILO
Transactions as of
Dec 29, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
1/5/2022, 05:18 PM
Date Of Original Report
Jan 3, 2022
Previous filing
Sep 30, 2021
Next filing
Mar 18, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILO Non-Qualified Stock Option Award $0 +171K $0.00 171K Dec 29, 2021 Common Stock 171K $0.15 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over the course of one year from grant with 100% vesting a year from the date of grant.
F2 The options were issued under the issuer's 2020 Omnibus Equity Incentive Plan.
F3 This Form 4/A deletes the second Non-Qualified Stock Option for 171,233 shares erroneously reported in the original Form 4 filed on January 3, 2022.